维普期刊资源整合服务平台（V6.5）

199篇 您的检索式：作者名="Kaira"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer显示文摘	Kaira K Oriuchi N Shimizu K	2009	Cancer Sci2009，100，4：	1
2	Usefulness of FDG- PET for early prediction of the response to gefitinib in non-small cell lung cancer显示文摘	Sunaga N Oriuchi N Kaira K	2008	Lung Cancer2008，59，2：	1
3	Clinicopathological features of patients with bronchial associated lymphoid tissue 显示文摘	Imai H Sunaga N Kaira K	2009	Intern Med2009，48，5：	1
4	The role of tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy显示文摘	Kaira K Takahashi T Murakami H	2012	IntJ Clin Oncol2012，，：	1
5	Strategies for CT radia- tion dose optimization显示文摘	Kaira MK Maher MM Toth TL	2004	Rdiology2004，230，：	1
6	Comparison of platinum com- bination re-challenge therapy and docetaxel monotherapy in non- small cell lung cancer patients previously treated with platinum- based chemoradiotherapy显示文摘	Imai H Kaira K Mort K	2015	Springerplus2015，4，：	1
7	Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer显示文摘	hnai H Kaira K Oriuchi N	2010	Anticancer Res2010，30，12：	1
8	Biologic correlates of ^18F-FDG uptake on PET in pulmonary pleomorphic carcinoma显示文摘	Kaira K Endo M Abe M	2011	Lung Cancer2011，71，：	1
9	Prognostic significanceof L-type amino acid transporter 1 (LAT1) and 4F2 heavychain (CD98) expression in stage I pulmonaryadenocarcinoma显示文摘	Kaira K Oriuchi N Imai H	2009	Lung Cancer2009，66，1：	1
10	Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the iung显示文摘	Kaira K Oriuchi N Imai H	2008	Pathol Res Pract2008，204，8：	1
11	L-type amino acid transport er 1 and CD98 expression in primary and metastatic sites of hu manneoplasms显示文摘	Kaira K Oriuchi N Imai H	2008	CancerSci2008，99，12：	1
12	The role of βⅢ-tubulin in non-small cell lung cancer patients treated by taxane-based chem- otherapy显示文摘	Kaira K Takahashi T Murakami H	2013	IntJClinOncol2013，18，3：	1
13	Usefulness of FDG- PET for early prediction of the response to gefitinib in non-small cell lung cancer显示文摘	Sunaga N Oriuchi N Kaira K	2007	Lung Cancer2007，1，：	1
14	Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer显示文摘	Kaira K Naito T Takahashi T	2010	Lung Cancer2010，68，1：	1
15	Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in pa- tients with pancreatic cancer显示文摘	Kaira K Arakawa K Shimizu K	2015	Am J Transl Res2015，7，2：	1
16	Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations:a pooled analysis of published reports显示文摘	Shukuya T Takahashi T Kaira R	2011	Cancer Sci2011，102，：	1
17	Prognostic significance of L-type amino acid transporter 1(LAT1)and 4F2 heavy chain(CD98)expression in stage I pulmonary adenocarcinoma显示文摘	KAIRA K ORIUCHI N IMAI H	2009	Lung Can-cer2009，66，1：	1
18	Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer显示文摘	Kyoichi Kaira Tateaki Naito Toshiaki Takahashi Eriko Ayabe Rai Shimoyama Rieko Kaira Akira Ono Satoshi Igawa Takehito Shukuya Haruyasu Murakami Asuka Tsuya Yukiko Nakamura Masahiro Endo Nobuyuki Yamamoto	2009	Lung Cancer2009，，1：	1
19	Phase Ⅱ study of weekly docetaxel and cisplatin in patients with nonsmall cell lung cancer显示文摘	Kaira K Takise A Minato K	2005	Anti-cancer Drugs2005，16，4：	1
20	L-type amino acid transporter I (LATl)is frequently expressed in thymic carcinomas but is absent in thymomas显示文摘	Kaira K Oriuchi N Imai H	2009	J Surg Oncol2009，99，7：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示